Ozkaya Esen
Department of Dermatology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
Acta Derm Venereol. 2007;87(6):517-20. doi: 10.2340/00015555-0307.
The principles behind the primary localization of lesions in fixed drug eruption are still unknown. Studies investigating the predilection areas indicated drug-related, trauma-related or inflammation-related specific site involvement in fixed drug eruption. This study presents new findings of primary site involvement on the maximal points of Head's zones. In the 3 cases reported here, fixed drug eruption lesions were located at specific sites; the so-called maximal points of Head's zones, which are known to be the most active dermatomal areas of an underlying visceral pathology. An underlying internal disturbance was found in all 3 patients, corresponding to the organ-related maximal point of Head's zones in each case. In conclusion, the primary location of the fixed drug eruption lesions on the maximal points of the Head's zones according to the well-known neurophysiological map is an important observation in studying the predilection areas.
固定性药疹中皮损初始定位背后的原理仍不清楚。研究固定性药疹好发部位的调查表明,其与药物、创伤或炎症相关的特定部位受累有关。本研究展示了关于初始部位累及希德分区最大点的新发现。在本文报道的3例病例中,固定性药疹皮损位于特定部位,即所谓的希德分区最大点,这些点已知是潜在内脏病变最活跃的皮节区域。在所有3例患者中均发现了潜在的内部紊乱,分别对应于各病例中与器官相关的希德分区最大点。总之,根据著名的神经生理图谱,固定性药疹皮损在希德分区最大点的初始定位是研究好发部位的一项重要观察结果。